In the first episode of our new video series, The Cure Chronicles, we interview Dr. Marcus Conant, who treated thousands of patients with HIV/AIDS when the disease first arose. While running the inpatient dermatology service at the University of California San Francisco, Dr. Conant identified Kaposi's Sarcoma in patients seeking treatment. Before anyone understood the impact the HIV virus would have on the world, Dr. Conant took the lead in forming the Kaposi’s Sarcoma Research & Education Foundation in 1982, which later became the San Francisco AIDS Foundation. Dr. Conant conducted early clinical trials, persevering despite seeing 94% of patients die during the epidemic’s first years. His clinical experience sensitized him to the suffering caused by the disease. As a physician with a holistic perspective, Dr. Conant’s work expanded beyond the strictly clinical, to include education, research, and advocacy.

About The Cure Chronicles:

There are more than 38 million people in the world currently living with HIV/AIDS. At American Gene Technologies® (AGT™), we believe there is hope for a cure. But it will take everyone working together to make it a reality and permanently end the suffering of millions of people living with HIV today.

AGT is testing a single-infusion cell therapy (AGT103-T) to hopefully cure people living with HIV. Meanwhile, we want to spotlight some of the many people in the HIV community who strive to keep hope alive and tip the odds toward success.

The Cure Chronicles video series features thoughtful conversations with people living with HIV, advocates, medical experts, policymakers, and others working hard toward the shared goal of ending the devastating HIV epidemic.

If you like this video, please subscribe to our channel: https://www.youtube.com/channel/UCqRz...

Also, please leave us a comment to let us know how you liked it as well as any additional subjects you’d like us to cover.

About American Gene Technologies:

AGT is a clinical-stage, gene and cell therapy company in Rockville, Maryland with a proprietary gene-delivery platform for rapid drug development of infectious diseases, cancers, and inherited disorders. AGT's mission is to transform people's lives through genetic medicines that rid the body of disease.

Visit our website: https://www.americangene.com

Subscribe to our newsletter: https://bit.ly/3ughPNR

Follow AGT on social media!

Twitter:
Jeff - @jeffreygalvin -   / jeffreygalvin  
AGT™ - @americangene -   / americangene  

LinkedIn:
Jeff -   / jeff-galvin  
AGT™ -   / amer.  .

Facebook:   / amerigene  

Instagram:   / americangenetechnologies